The Pharmaceutical Journal
Vol 280 No 7490 p211
23 February 2008

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Announcements

• Antidepressant products

Announcements

Antidepressant products
The Medicines and Healthcare products Regulatory Agency is asking companies that hold marketing authorisations for antidepressant medicines to update their products’ warnings on suicidal thoughts and behaviour, particularly with respect to the increased risk to young adults and the need for close monitoring of patients.

Agreed wording for these warnings is available online